Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cutler B. S., Forbes A. P., Ingersoll F. M., Scully R. E. Endometrial carcinoma after stilbestrol therapy in gonadal dysgenesis. N Engl J Med. 1972 Sep 28;287(13):628–631. doi: 10.1056/NEJM197209282871302. [DOI] [PubMed] [Google Scholar]
- Frasier S. D., Smith F. G., Jr Effect of estrogens on mature height in tall girls: a controlled study. J Clin Endocrinol Metab. 1968 Mar;28(3):416–419. doi: 10.1210/jcem-28-3-416. [DOI] [PubMed] [Google Scholar]
- Herbst A. L., Ulfelder H., Poskanzer D. C. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971 Apr 15;284(15):878–881. doi: 10.1056/NEJM197104222841604. [DOI] [PubMed] [Google Scholar]
- Schoen E. J., Solomon I. L., Warner O., Wingerd J. Estrogen treatment of tall girls. Am J Dis Child. 1973 Jan;125(1):71–74. doi: 10.1001/archpedi.1973.04160010045010. [DOI] [PubMed] [Google Scholar]
- Tanner J. M., Whitehouse R. H., Marshall W. A., Carter B. S. Prediction of adult height from height, bone age, and occurrence of menarche, at ages 4 to 16 with allowance for midparent height. Arch Dis Child. 1975 Jan;50(1):14–26. doi: 10.1136/adc.50.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Whitelaw M. J. Experiences in treating excessive height in girls with cyclic oestradiol valerate. A ten year survey. Acta Endocrinol (Copenh) 1967 Mar;54(3):473–484. doi: 10.1530/acta.0.0540473. [DOI] [PubMed] [Google Scholar]
- Wiedemann E., Schwartz E. Suppression of growth hormone-dependent human serum sulfation factor by estrogen. J Clin Endocrinol Metab. 1972 Jan;34(1):51–58. doi: 10.1210/jcem-34-1-51. [DOI] [PubMed] [Google Scholar]